Catálogos >
Visionix >
nexy A.I

nexy A.I
1 / 8Páginas

Excertos do catálogo

The next step in preventative eye health screening

Retinal health assessment A combination of an automated fundus camera and dedicated AI solution, the Nexy A.I delivers extensive retinal health assessments in under 5-minutes.

Abrir o catálogo na página 3

Championing visual health The Nexy A.I solution allows you to expand your visual health capabilities. By playing an active role in retinal screening, you can support the health of your community and enhance your customer experience. PARTNERSHIP IN ACTION As a Nexy A.I innovation partner, you will receive service training, sales guidance and ongoing support from Visionix®.

Abrir o catálogo na página 4

Extensive screening Imaging with a fully automated fundus camera Secured data transfer and encryption Detailed report Start to finish in 5 minutes The most important thing with retinal disease is catching it as early as possible. Any technology or solution that supports that goal can help improve patient outcomes, and has an important role to play in visual health. Dr. Eugenio Innocenti Consultant Ophthalmologist (Dusseldörf) EXPERT VALIDATED Reports validated against expert assessment CE CERTIFIED Class II registered A.I with CE certification ESTABLISHED QUALITY >90% sensitivity and...

Abrir o catálogo na página 5

Validated solution The Nexy A.I solution covers 13 common retinal pathologies. With most retinal diseases, the primary goal of treatment is to slow disease progression and preserve the retina and associated vision. The ability of the A.I. to correctly tag a positive result: The ability of the A.I to correctly tag a negative result: The Nexy A.I camera utilises an innovative cross-polarized light technology that provides excellent image quality while maintaining a compact footprint. • obotic movements: auto-alignment, R auto-focus and auto-capture • utomatic capture of high-quality A images...

Abrir o catálogo na página 6

13 in 1 Key retinal pathologies World Health Organization: Globally, at least This includes approximately PEOPLE HAVE VISION IMPAIRMENT PEOPLE WITH DIABETIC RETINOPATHY which could have been prevented or has yet to be addressed.1 Diabetic retinopathy Retinal vessel occlusion Pathologic myopia Exudative ARMD Retinitis pigmentosa Nonexudative ARMD Epiretinal membrane Optic disc atrophy Central serous chorioretinopathy Suspicious glaucoma Macular hole Retinal detachment Retinal artery occlusion As a consultant ophthalmologist I welcome A.I technology. It is clear that A.I has a major...

Abrir o catálogo na página 7

This document is not contractual. ©kosept - ©Photos: E.Bienvenu - ind10 - 03/22 Features and specifications are subject to change without prior notice. LUNEAU TECHNOLOGY SAS 2 Rue Roger Bonnet, 27340 Pont-de-l’Arche - France Tél. + 33 232 989 132 - Fax + 33 235 020 294 contact@visionix.c

Abrir o catálogo na página 8